The BCL2 code to dopaminergic development and Parkinson's disease

Trends in Molecular Medicine

Volumn 19, Issue 4, 2013, Pages 211-216

  Van der Heide, Lars P ^a   Smidt, Marten P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

BCL2; Cell death; Dopamine; NURR1; Parkinson's disease; PITX3; Substantia nigra

Indexed keywords

NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN BCL 2; TRANSCRIPTION FACTOR PITX3;

CELL DEATH; CELL SELECTION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EMBRYO DEVELOPMENT; HUMAN; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; REVIEW;

ADULT; ANIMALS; CELL DEATH; DOPAMINE; HOMEODOMAIN PROTEINS; HUMANS; MITOCHONDRIAL DISEASES; NEURONS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS C-BCL-2; SUBSTANTIA NIGRA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84875859455     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2013.02.003     Document Type: Review

References (39)

1. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
2. Exner N., et al. Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J. 2012, 31:3038-3062.
3. Burbulla L.F., et al. Balance is the challenge - the impact of mitochondrial dynamics in Parkinson's disease. Eur. J. Clin. Invest. 2010, 40:1048-1060.
4. Liste I., et al. The generation of dopaminergic neurons by human neural stem cells is enhanced by Bcl-XL, both in vitro and in vivo. J. Neurosci. 2004, 24:10786-10795.
5. Rangasamy S.B., et al. Neurotrophic factor therapy for Parkinson's disease. Prog. Brain Res. 2010, 184:237-264.
6. Oo T.F., Burke R.E. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Brain Res. Dev. Brain Res. 1997, 98:191-196.
7. Zhang J., et al. Essential function of HIPK2 in TGFβ-dependent survival of midbrain dopamine neurons. Nat. Neurosci. 2007, 10:77-86.
8. Smidt M.P., Burbach J.P.H. How to make a mesodiencephalic dopaminergic neuron. Nat. Rev. Neurosci. 2007, 8:21-32.
9. Zetterström R.H., et al. Dopamine neuron agenesis in NURR1-deficient mice. Science 1997, 276:248-250.
10. Saucedo-Cardenas O., et al. NURR1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:4013-4018.
11. Wallén A., et al. Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice. Exp. Cell Res. 1999, 253:737-746.
12. Smidt M.P., Burbach J.P.H. Terminal differentiation of mesodiencephalic dopaminergic neurons: the role of NURR1 and PITX3. Adv. Exp. Med. Biol. 2009, 651:47-57.
13. Smidt M.P., et al. Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene PITX3. Development 2004, 131:1145-1155.
14. Hwang D-Y., et al. Selective loss of dopaminergic neurons in the substantia nigra of PITX3-deficient aphakia mice. Brain Res. Mol. Brain Res. 2003, 114:123-131.
15. Nunes I., et al. PITX3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:4245-4250.
16. Maxwell S.L., et al. PITX3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development. Dev. Biol. 2005, 282:467-479.
17. Jacobs F.M.J., et al. Identification of Dlk1, Ptpru and Klhl1 as novel NURR1 target genes in meso-diencephalic dopamine neurons. Development 2009, 136:2363-2373.
18. Alvarez-Fischer D., et al. Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. Nat. Neurosci. 2011, 14:1260-1266.
19. Peng C., et al. PITX3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons. J. Neurosci. 2011, 31:12802-12815.
20. Jankovic J., et al. The role of NURR1 in the development of dopaminergic neurons and Parkinson's disease. Prog. Neurobiol. 2005, 77:128-138.
21. Sonnier L., et al. Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J. Neurosci. 2007, 27:1063-1071.
22. Jacobs F.M.J., et al. Retinoic acid-dependent and -independent gene-regulatory pathways of PITX3 in meso-diencephalic dopaminergic neurons. Development 2011, 138:5213-5222.
23. Engele J. Changing responsiveness of developing midbrain dopaminergic neurons for extracellular growth factors. J. Neurosci. Res. 1998, 51:508-516.
24. Granholm A.C., et al. Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. J. Neurosci. 2000, 20:3182-3190.
25. Jacobs F.M.J., et al. Retinoic acid counteracts developmental defects in the substantia nigra caused by PITX3 deficiency. Development 2007, 134:2673-2684.
26. Chipuk J.E., et al. The BCL2 family reunion. Mol. Cell 2010, 37:299-310.
27. Jackson-Lewis V., et al. Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J. Comp. Neurol. 2000, 424:476-488.
28. Groc L., et al. Bax, Bcl-2, and cyclin expression and apoptosis in rat substantia nigra during development. Neurosci. Lett. 2001, 306:198-202.
29. García-Sáez A.J. The secrets of the BCL2 family. Cell Death Differ. 2012, 19:1733-1740.
30. Levy O.A., et al. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 2009, 14:478-500.
31. Johnson B.N., et al. The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:6283-6288.
32. Hoppins S., et al. The soluble form of Bax regulates mitochondrial fusion via MFN2 homotypic complexes. Mol. Cell 2011, 41:150-160.
33. Sheridan C., et al. Bax- or Bak-induced fission can be uncoupled from cytochrome C release. Mol. Cell 2008, 31:570-585.
34. Haubenberger D., et al. Association of transcription factor polymorphisms PITX3 and EN1 with Parkinson's disease. Neurobiol. Aging 2011, 32:302-307.
35. Le W., et al. Decreased NURR1 gene expression in patients with Parkinson's disease. J. Neurol. Sci. 2008, 273:29-33.
36. Alavian K.N., et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat. Cell Biol. 2011, 13:1224-1233.
37. Chen Y-B., et al. Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J. Cell Biol. 2011, 195:263-276.
38. Wang S., et al. 17β-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2. J. Mol. Neurosci. 2011, 45:236-245.
39. van der Heide L.P., et al. TGFβ activates mitogen- and stress-activated protein kinase-1 (MSK1) to attenuate cell death. J. Biol. Chem. 2011, 286:5003-5011.